Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy.
Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy. Br J Radiol. 2020 Mar; 93(1107):20190669.